Clinical Trials Logo

Stress Disorders, Post-Traumatic clinical trials

View clinical trials related to Stress Disorders, Post-Traumatic.

Filter by:

NCT ID: NCT03232060 Completed - Clinical trials for Post Traumatic Stress Disorder

Transcendental Meditation and Reduced Trauma Symptoms in Women Inmates

Start date: March 2014
Phase: N/A
Study type: Interventional

This pilot study investigated the trauma reducing effects of the Transcendental Meditation program on female prisoners The study was conducted over the 4 month period and measured total trauma symptoms at baseline and posttest in both the TM experimental group and waitlist controls

NCT ID: NCT03230890 Completed - Clinical trials for Stress Disorders, Post-Traumatic

HIRREM in Military Personnel

Start date: February 16, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects associated with the use of in-office High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM) for participants with symptoms of military-related traumatic stress. This is a single site, non-randomized, open label pilot study. Outcome measures collected before, and after the intervention evaluate effects on self-reported symptoms, autonomic cardiovascular regulation, functional measures, blood and saliva biomarkers of stress and inflammation, and network connectivity on whole brain, rest MRI testing. Self-reported symptom outcomes will also be collected remotely at 1, 3, and 6 months after completion of intervention. The study will assess feasibility in this cohort, focused on the Special Operations community, will provide estimates of effect size, and durability of symptom changes, while providing important pilot data for future proposals and investigations.

NCT ID: NCT03229915 Completed - Clinical trials for Stress Disorders, Post-Traumatic

CPT-fMRI Study for PTSD

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

Posttraumatic stress disorder (PTSD) is prevalent mental illness (~9% life-time) that results from exposure to trauma. As it is associated with vastly heterogeneous origins, accurate diagnosis and optimal treatment strategies are sometimes very difficult to achieve. No known biomarker exists, which makes it difficult to assess treatment response and functional outcomes. The recent brain imaging studies have suggested that PTSD patients show abnormal brain connectivity measured by functional magnetic resonance imaging (fMRI). The investigators propose that cognitive processing therapy may ameliorate this functional connectivity abnormality which may be related with their symptomatic improvement.

NCT ID: NCT03226132 Completed - Insomnia Clinical Trials

Improving Sleep to Reduce Risk for Substance Use Disorder

Start date: August 20, 2017
Phase: N/A
Study type: Interventional

Substance use disorders (SUDs) are a prevalent and impairing condition, particularly among trauma exposed individuals. The current proposal aims to address the critical need for targeted direct SUD prevention in this population by intervening on a novel, malleable risk factor for SUD common among trauma-exposed individuals: sleep disturbance. Sleep disturbance prospectively predicts the development of SUD and may confer risk for SUD by increasing stress reactivity, decreasing decision-making abilities, and ultimately promoting substance use to relieve negative affect, a core etiological factor in SUD. However, to our knowledge, no experimental studies have determined whether improving sleep leads to reductions in SUD risk. As such, the current study will use a randomized controlled trial design to test the effects of brief behavioral treatment for insomnia (BBTI) against a waitlist control among a sample of trauma-exposed young adults with poor sleep and risk for SUD (N = 60). We aim to determine the direct and indirect effects of condition (BBTI vs. waitlist control) on SUD symptoms, substance use-related problems, coping motives, and posttraumatic stress symptoms through improvements in sleep. Furthermore, we will test direct and indirect effects of condition on theoretically proposed mechanisms underlying the association between sleep disturbance and SUD risk (i.e., stress reactivity, cravings in response to stress).

NCT ID: NCT03225859 Completed - Clinical trials for Posttraumatic Stress Disorder

A Self-Management Program for Completers of Trauma-Focused Therapy for PTSD

EMPOwER
Start date: November 5, 2018
Phase: N/A
Study type: Interventional

Veterans who complete trauma-focused therapies (TFTs) report improvements in posttraumatic stress disorder symptoms, quality of life, and social and role functioning. However, many also report uncertainty regarding their ability to maintain and build upon progress made during TFTs following the end of treatment. Veterans who recently completed a course of TFT believe the likelihood of their ongoing success would be bolstered by mental health services that support additional practice and reinforcement of skills learned in TFT. Currently no evidence-based approach for post-TFT care exists; however, Veterans' reported treatment needs are well-suited to a therapist-assisted self-management approach. The objective of this project is to complete Stage 1 (intervention refinement and piloting) of the Stage Model of Treatment Development for a post-TFT therapist-assisted self-management program designed to help Veterans maintain or build upon gains made in TFT, increase self-efficacy for managing their PTSD symptoms, and enhance community engagement. The aims of the project are to: 1) Refine a self-management treatment protocol through eliciting feedback from experienced TFT providers on a draft of the self-management program, 2) Conduct a pilot open trial to assess the acceptability and feasibility of the self-management program, and 3) Explore the effects of the program on Veterans' confidence in managing their PTSD and Veterans' functioning, quality of life, community engagement, and mental health symptoms.

NCT ID: NCT03211013 Completed - Clinical trials for Posttraumatic Stress Disorder

Study of the Effects of Oxytocin on Attentional Bias and Startle in PTSD

Start date: July 10, 2017
Phase: Early Phase 1
Study type: Interventional

The investigators will test whether intranasal oxytocin (24 IU vs placebo) will induce effects on attention bias and startle comparable to those the investigators have shown to be induced by the presence (vs absence) of a service dog in Veterans diagnosed with PTSD. This possibility is suggested by a 2015 study showing that urinary oxytocin levels are elevated in association with mutual gaze between dogs and their owners.

NCT ID: NCT03206437 Completed - Anxiety Disorders Clinical Trials

Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli

Start date: June 20, 2017
Phase: N/A
Study type: Interventional

This study will evaluate the effects of Mindfulness-Based Stress Reduction (MBSR) on physiological reactivity. This study will focus on individuals with anxiety who will participate in an 8-week MBSR class. The investigators will test participants' reactivity to both predictable and unpredictable stimuli before and after the class to understand the physiological changes that may occur after to the intervention. Secondary measures include psychometric instruments and a delay discounting task.

NCT ID: NCT03200028 Completed - Clinical trials for Alcohol Use Disorder

CCTAP: Cognitive Control Training for Treatment of AUD-PTSD

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the feasibility of the revised brain training program with individuals diagnosed with Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD).

NCT ID: NCT03199742 Completed - Clinical trials for Stress Disorders, Post-Traumatic

Evaluation of a Mobile Phone App for Veterans With PTSD

Start date: July 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate a mobile phone app designed to help Veterans with PTSD. Participants in this study will be randomized to receive one of 2 possible mobile phone apps. The term "randomized" means that which app a participant receives will not be based on any characteristic or behavior of the participant, but will be determined solely by chance like a flip of a coin.

NCT ID: NCT03196999 Completed - Clinical trials for Post Traumatic Stress Disorder

Remotely Resolving Psychological Stress (Remote RePS)

Start date: November 30, 2017
Phase: N/A
Study type: Interventional

The investigators have developed a mobile app called Resolving Psychological Stress (REPS) for people with posttraumatic stress disorder (PTSD). The app will administer threat-related attention bias modification to individuals who score high on a PTSD checklist. This study will be administered remotely to individuals in the United States. The aims of the study are to explore feasibility, acceptability and usability of the app in an entirely remote study, as well as to explore the efficacy of the app at reducing attention bias and PTSD symptom severity.